
MicroStockHub
Abivax (ABVX) closed Friday down ~9% following a short report from Scorpion Research, which attacked the clinical development of the company’s ulcerative colitis candidate obefazimod.
Scorpion revealed it has a short position in Abivax. The firm claims that the asset exhibits “